• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Allergy Study Reveals Dead Sea Salt Solution as Effective as Nasal Steroids in Treating Sinus Issues, without Risks


News provided by

TriCord Pharmaceuticals

Jun 12, 2012, 03:00 ET

Share this article

Share this article


TULSA, Okla., June 12, 2012 /PRNewswire/ -- A new study published in this month's print issue of the International Forum of Allergy & Rhinology shows that treatment with Dead Sea salt (DSS) irrigations and sprays are as effective as topical nasal steroids in treating chronic rhinosinusitis (CRS) – a sinus condition that can obstruct nasal passages, making it difficult to breathe. CRS is often accompanied by swelling around the eyes and face, facial pain and/or headaches.

(Logo:  http://photos.prnewswire.com/prnh/20120612/CL23285LOGO)

The study, led by Michael Friedman, MD, otolaryngologist, Professor and Chairman, Section of Otolaryngology, Advocate Illinois Masonic Medical Center and Professor and Chairman, Section of Sleep Surgery, Rush University Medical Center, provides evidence of the medically significant difference DSS brings to treating CRS. When comparing the results of LAVI Dead Sea Sinus Solutions – currently the only natural, DSS line of products available for patients – to that of typical saline nasal irrigations and nasal steroids, the study found the DSS regimen was as effective as using nasal steroids.

"The mineral make-up of Dead Sea salts provide the same anti-inflammatory benefit as prescription nasal steroids," said Dr. Friedman.  "As physicians, this offers us a natural alternative for our patients. Further, study findings demonstrate that the health benefits of Dead Sea salts also help in the treatment of allergies and other respiratory illnesses."

Nasal steroids have been used to treat CRS because of the ability to reduce inflammation. For the same reason, it's also the most highly prescribed medication used to treat nasal allergies, which affect nearly 50 million people in the United States alone. Yet a 2010 nasal allergy survey revealed that nearly 64 percent of patients discontinue use of nasal steroid prescriptions due to the unwanted side effects.  The results of this most recent study suggest that natural DSS solutions can be used as an alternative.

Study Overview

In the study, 114 adults presenting complaints of CRS-related symptoms completed a Sino-Nasal Outcomes Test 20 (SNOT-20) and underwent an endonasal examination, acoustic rhinometry and smell testing. Patients were randomized into two groups: the experimental group that self-administered hypertonic (highly concentrated) DSS spray and DSS irrigation and the control group that self-administered topical nasal steroid spray and hypertonic saline irrigation.

This is the second study conducted by Dr. Friedman to prove the efficacy of DSS. A study published in the June 2006 issue of The Laryngoscope found that hypertonic saline irrigation, though of some value, can cause inflammation that increases mucus and causes excess secretion, whereas DSS, even in hypertonic form, has an anti-inflammatory effect, thereby naturally reducing swelling and congestion. The results of this earlier study provide evidence that DSS is superior to other saline for the treatment of CRS and significantly improves patient quality of life.

Allergy Effects

According to the Asthma and Allergy Foundation of America, allergies – specifically hay fever – are the fifth leading chronic disease for adults, resulting in nearly 4 million missed or lost workdays each year and costing an estimated $8 billion in healthcare spending.

"Many people down play the effects of allergies," said Friedman. "However, the facts remain. Allergies can have a debilitating impact on a person's quality of life and, if left untreated, can lead to even more severe conditions."

Practicing good nasal hygiene, including using natural nasal sprays and washes, helps to prevent allergy symptoms and related illnesses by flushing allergens, toxins, germs and other pollutants from the nasal passages. It also decreases reliance on or the need for expensive medical procedures, prescriptions and over-the-counter medications, which can often cause side effects.

DSS irrigations and sprays offer natural solutions that are ideal for anyone, especially those for whom prescription or medicated sinus or allergy products may be contraindicated, including cancer patients, older Americans, young children and those undergoing post-operative care. Additionally, DSS is a safe solution for women who are pregnant and those with high blood pressure or on sodium-restricted diets.

Not all Salts Are Created Equal

Most saline-based sinus products – including those claiming to be derived from sea salt – are nearly 100 percent sodium chloride (common table salt), which in highly concentrated forms, can actually cause an increase in mucus production and potentially damage the cilia – or hairs – inside the nose. Dead Sea salts are rich in minerals including magnesium, potassium, and calcium, known to provide an anti-inflammatory effect, reducing swelling and congestion.

About the Dead Sea

For thousands of years people have sought – and science has recognized – the Dead Sea as a place of natural healing and relief from dermatological, inflammatory and respiratory ailments such as psoriasis and eczema. This same natural healing power has now been clinically recognized in the treatment and prevention of allergy symptoms and other related illnesses.

About LAVI Dead Sea Sinus Solutions

LAVI Dead Sea Sinus Solutions is an all natural and non-addictive line of nasal care products made from purified salts extracted from the Dead Sea.  LAVI Dead Sea Sinus Solutions are ideal for anyone, including women who are pregnant, those with high blood pressure, and especially for those for whom prescription or medicated sinus or allergy products may be contraindicated, including cancer patients, older Americans, young children and those undergoing post-operative care. The patented line of LAVI Dead Sea Sinus Solutions, which debuted in 2011, replaced the company's Oasis Nasal Wash and Oasis Nasal Spray.  LAVI is manufactured by TriCord Pharmaceuticals LLC, based in Tulsa, Okla.

For more information about the studies or DDS or LAVI Sinus Solutions, please visit www.LAVImed.com. 

SOURCE TriCord Pharmaceuticals

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.